Molson Coors (TAP) shifts EMEA&APAC leadership as Philip Whitehead takes medical leave

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Molson Coors Beverage Company disclosed a temporary leadership change in its international business. Philip Whitehead, President and Chief Executive Officer of the EMEA&APAC segment, is stepping away from his role due to a medical condition. During his medical leave, Simon Kerry, currently Managing Director of the U.K. and Ireland regional business, will serve as interim Managing Director of the EMEA&APAC business.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Announcement date: June 24, 2026 Senior notes coupon: 3.800% Senior Notes maturity: 2032

3 metrics

Announcement date June 24, 2026 Date Molson Coors reported EMEA&APAC leadership change

Senior notes coupon 3.800% Coupon on Senior Notes due 2032 listed on NYSE

Senior Notes maturity 2032 Maturity year of 3.800% Senior Notes

Key Terms

EMEA&APAC business, Managing Director, Senior Notes

3 terms

EMEA&APAC business financial

"the President and Chief Executive Officer of the Company’s EMEA&APAC business"

Managing Director financial

"Simon Kerry, the Managing Director of the Company’s U.K. and Ireland regional business"

Senior Notes financial

"3.800% Senior Notes due 2032"

Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

06/24/2026 - 09:02 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 24, 2026

MOLSON COORS BEVERAGE COMPANY

(Exact name of registrant as specified in its charter)

Commission File Number: 001-14829

Delaware	84-0178360
(State or other jurisdiction of incorporation)	(IRS Employer Identification No.)

P.O. Box 4030, BC555, Golden, Colorado 80401

111 Boulevard Robert-Bourassa, 9th Floor, Montréal, Québec, Canada H3C 2M1

(Address of principal executive offices, including zip code)

(303) 279-6565 / (514) 521-1786

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbols	Name of each exchange on which registered
Class A Common Stock, par value $0.01	TAP.A	New York Stock Exchange
Class B Common Stock, par value $0.01	TAP	New York Stock Exchange
3.800% Senior Notes due 2032	TAP 32	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 24, 2026, Molson Coors Beverage Company (the “Company”) announced that Philip Whitehead, the President and Chief Executive Officer of the Company’s EMEA&APAC business, will be temporarily stepping away from his role due to a medical condition. The Company also announced that Simon Kerry, the Managing Director of the Company’s U.K. and Ireland regional business, will serve as interim Managing Director of the Company’s EMEA&APAC business during Mr. Whitehead’s medical leave period.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			MOLSON COORS BEVERAGE COMPANY

Date:	June 24, 2026	By:	/s/ Natalie G. Maciolek
			Natalie G. Maciolek
			Chief Legal, Communications & Government Affairs Officer and Secretary

Source: View Original Filing on SEC EDGAR

FAQ

What leadership change did Molson Coors (TAP) announce for its EMEA&APAC business?

Molson Coors announced that Philip Whitehead, President and CEO of its EMEA&APAC business, will temporarily step away due to a medical condition. During his leave, Simon Kerry will act as interim Managing Director overseeing the EMEA&APAC operations.

Who is Philip Whitehead in relation to Molson Coors (TAP)?

Philip Whitehead is the President and Chief Executive Officer of Molson Coors’ EMEA&APAC business. The company stated he will temporarily step away from this leadership role because of a medical condition, prompting an interim management arrangement.

Who will lead Molson Coors (TAP) EMEA&APAC business during Philip Whitehead’s leave?

During Philip Whitehead’s medical leave, Simon Kerry will serve as interim Managing Director of Molson Coors’ EMEA&APAC business. Kerry is currently the Managing Director of the company’s U.K. and Ireland regional business and will assume broader regional responsibilities.

What is Simon Kerry’s current role at Molson Coors (TAP)?

Simon Kerry is the Managing Director of Molson Coors’ U.K. and Ireland regional business. The company also designated him as interim Managing Director of its EMEA&APAC business while Philip Whitehead is away on medical leave, expanding his management scope.

When did Molson Coors (TAP) announce the EMEA&APAC leadership change?

Molson Coors announced the EMEA&APAC leadership change on June 24, 2026. On that date, the company reported Philip Whitehead’s temporary departure for medical reasons and appointed Simon Kerry as interim Managing Director for the EMEA&APAC business.

Filing Exhibits & Attachments

4 documents